|
|
13Motowo Mizuno
![]() Summary for 2004 [at-glance overview of Motowo Mizuno work for the selected year as suggested by data mining algorithms]This is an Authoratory overview of author Motowo Mizuno. According to available data, in 2004 Motowo Mizuno published at least 13 articles. This work was completed in collaboration with several authors including Okada, Hiroyuki and Shiratori, Yasushi. Many other authors have collaborated with Motowo Mizuno as well. There is no information about the funding or the grants awarded to support this work.
Motowo Mizuno is a key opinion leader on Antigens, CD55, Chaperonin 60. This author's highest rank is 4 when compared to all other authors using the keyword Antigens, CD55. Analysis of the article abstracts and the titles suggests that Motowo Mizuno professional interests are focused around "gastric epithelial cells", "serum daf concentrations" and "complement regulatory proteins". These might also be referred to as "helicobacter pylori", "malt lymphoma" or "decay-accelerating factor". Statistical analysis shows that Motowo Mizuno's writing is likely to contains terms "pylori", "patients", "gastric", "expression", "daf" and "cells".
The majority of Motowo Mizuno articles are affiliated with Department of Pathology, Medicine and Medical Science (Medicine 1), Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan. Luckily, one email address is on file. Images [images we found on the Internet for Motowo Mizuno]loading...
Do you know Motowo Mizuno who matches the profile above? Click the photo and let us know!
Alternative names (1) [other authors with names similar to Motowo Mizuno]Year 2004 Charts [Motowo Mizuno frequent coauthors and the most common unique vocabulary terms for the selected year]Historical Performance Charts [graphical overview of Motowo Mizuno publication and funding history for the range of years]Emails (1) [email addresses extracted from Motowo Mizuno affiliations]hidden to prevent spam, click here to reveal Motowo Mizuno Coauthors (33) [all coauthors with the number of joint publications] Other [context-specific ads]Affiliations (4) [condensed summary of the Motowo Mizuno affiliations, the leading number and the color conveys importance]- 7Department of Pathology, Medicine and Medical Science (Medicine 1), Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan.
3Department of Medicine and Medical Science, Okayama University Graduate School of Medicine and Dentistry. Dentistry, Japan. 1Department of Internal Medicine, Nippon Kokan Fukuyama Hospital, Japan. 1Department of Internal Medicine, Nippon Kokan Fukuyama Hospital.
Key Opinion Leader In [Motowo Mizuno is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]- 4Antigens, CD55 | 4Chaperonin 60 | 15Lymphoma, B-Cell, Marginal Zone | 28Helicobacter pylori | 40Colitis, Ulcerative | 147Helicobacter Infections
Keywords (32) [keywords assigned to Motowo Mizuno articles by PubMed, the leading number and the color conveys importance]- 13Humans | 9Male | 8Adult | 7Middle Aged | 7Aged | 7Female | 6Helicobacter pylori | 4Antigens, CD55 | 3Aged, 80 and over | 3Chaperonin 60 | 3Colitis, Ulcerative | 3Helicobacter Infections | 3Lymphoma, B-Cell, Marginal Zone | 2RNA, Messenger | 2Recombinant Proteins | 2Stomach Neoplasms | 2Neoplasm Staging | 2Antigens, CD | 2Biological Markers | 2Gastric Mucosa | 2Immunohistochemistry | 2Gastroscopy | 2Membrane Glycoproteins | 2Intestinal Mucosa | 2Adenocarcinoma | 2Anti-Bacterial Agents | 2Esophagus | 2Amoxicillin | 1Gene Expression Regulation, Neoplastic | 1Cytokines | 1Colon | 1Interleukin-8
Motowo Mizuno Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Motowo Mizuno might be a good expert witness on these terms]- 40pylori | 28patients | 22gastric | 20expression | 18daf | 17cells | 17helicobacter | 17lymphoma | 13serum | 13protein | 13cell | 12factor | 12eradication | 12malt | 11disease | 10uc | 10hsp60 | 9increased | 9il-8 | 9cancer | 8concentrations | 8human | 8response | 8therapy | 8decay-accelerating | 7surface | 7antibodies | 7heat-shock | 7cd55 | 6colitis | 6identified | 6ulcerative
- 13helicobacter pylori | 11malt lymphoma | 8decay-accelerating factor | 7heat-shock protein | 7pylori eradication | 6ulcerative colitis | 6daf concentrations | 5serum daf | 5eradication therapy | 5pylori hsp60 | 5cure rate | 5epithelial cells | 5patients active | 5gastric epithelial | 5genetic polymorphism | 5juvenile polyps | 5regulatory proteins | 4serum antibodies | 4concentrations surface | 4pylori heat-shock | 4surface daf | 4daf expression | 4beta genetic | 4cell membrane | 3human gastric | 3lymphoma eradication | 3mrna expression | 3uc patients | 3increased serum | 3complement-regulatory protein | 3gastric malt | 3response gastric
- 5gastric epithelial cells | 5serum daf concentrations | 5complement regulatory proteins | 4pylori eradication therapy | 4surface daf expression | 4pylori heat-shock protein | 4helicobacter pylori heat-shock | 4beta genetic polymorphism | 4primary form pdp | 4esophageal squamous cell | 4squamous cell carcinoma | 4mucosa-associated lymphoid tissue | 3human gastric epithelial | 3gastric malt lymphoma | 3gastric mucosa-associated lymphoid | 3pre-existing reflux esophagitis | 3decay-accelerating factor cd55 | 3patient gastric-mucosa-associated lymphoid-tissue | 3isolated patient gastric-mucosa-associated | 3gastric-mucosa-associated lymphoid-tissue lymphoma | 3genotype cure rate | 2decay-accelerating factor complement-regulatory | 2cd55 patients active | 2decay-accelerating factor detected | 2antibodies helicobacter pylori | 2daf concentrations surface | 2toll-like receptor-triggered pathway | 2polyps stomach gastric | 2il-1 beta genetic | 2blood cells decay-accelerating | 2europaeus agglutinin i-binding | 2receptor-triggered pathway cultured
Reader's Comments (0) [comments posted by readers of Motowo Mizuno profile]Funding (0) [selected NIH grants to Motowo Mizuno and the award amounts for recent years]- award information is not available
Motowo Mizuno Articles (13) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells. (2004) >> Department of Medicine and Medical Science (Medicine 1), Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. 2Fujinami, Yoshihito, 24Zhao, Ying, 4Takenaka, Ryuta, 13Mizuno, Motowo, 3Toyokawa, Tatsuya, 10Oguma, Keiji, 6Yokota, Kenji, 1Ayada, Kiyoshi, 17Okada, Hiroyuki, 38Shiratori, Yasushi, 2Lin, Song-Nan.Pneumocystis carinii pneumonia in patients with ulcerative colitis. (2004) >> 3Tatsukawa, Masashi, 1Tanimoto, Yasushi, 4Takenaka, Ryuta, 13Mizuno, Motowo, 1Nasu, Junichiro, 1Toshimori, Junichi, 1Wato, Masaki, 17Okada, Hiroyuki, 38Shiratori, Yasushi.Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma. (2004) >> Department of Medicine and Medical Science (Medicine 1), Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan. 18Fujita, Teizo, 4Makidono, Chiho, 8Yamamoto, Kazuhide, 13Mizuno, Motowo, 9Okazaki, Hiroaki, 4Hiraoka, Sakiko, 6Nasu, Junichirou, 17Okada, Hiroyuki, 38Shiratori, Yasushi, 1Shimo, Kimihiro.Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease. (2004) >> Department of Internal Medicine, Nippon Kokan Fukuyama Hospital, Japan. 2Nagahara, Yasuhiro, 2Yoshida, Tomowo, 3Take, Susumu, 8Yamamoto, Kazuhide, 13Mizuno, Motowo, 3Ishiki, Kuniharu, 10Oguma, Keiji, 6Yokota, Kenji, 17Okada, Hiroyuki, 38Shiratori, Yasushi.Serum antibodies to Helicobacter pylori and its heat-shock protein 60 correlate with the response of gastric mucosa-associated lymphoid tissue lymphoma to eradication of H. pylori. (2004) >> Department of Medicine and Medical Science (Medicine 1), Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan. 4Takenaka, Ryuta, 13Mizuno, Motowo, 3Toyokawa, Tatsuya, 16Yoshino, Tadashi, 10Oguma, Keiji, 6Yokota, Kenji, 10Sugiyama, Toshiro, 32Asaka, Masahiro, 2Yamasaki, Rie, 17Okada, Hiroyuki, 38Shiratori, Yasushi.[A case of gastric metastasis of small cell cancer of the lung, regression of the gastric lesion after chemotherapy] (2004) >> Department of Internal Medicine, Nippon Kokan Fukuyama Hospital. 2Nagahara, Yasuhiro, 2Yoshida, Tomowo, 1Imada, Takayuki, 3Okamoto, Tsuyoshi, 3Take, Susumu, 13Mizuno, Motowo, 1Hori, Shinichiro, 1Ishioka, Hidehiko, 3Ishiki, Kuniharu, 1Motoi, Makoto.Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagus. (2004) >> Department of Medicine and Medical Science (Medicine 1), Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. 18Fujita, Teizo, 4Makidono, Chiho, 8Yamamoto, Kazuhide, 13Mizuno, Motowo, 9Okazaki, Hiroaki, 4Hiraoka, Sakiko, 6Nasu, Junichirou, 1Terada, Ryo, 17Okada, Hiroyuki, 38Shiratori, Yasushi.Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitis. (2004) >> Department of Medicine and Medical Science, Okayama University Graduate School of Medicine and Dentistry, Japan. 18Fujita, Teizo, 4Makidono, Chiho, 4Tsuji, Takao, 8Yamamoto, Kazuhide, 13Mizuno, Motowo, 9Okazaki, Hiroaki, 4Hiraoka, Sakiko, 6Nasu, Junichirou, 17Okada, Hiroyuki, 38Shiratori, Yasushi.Increased serum concentrations and surface expression on peripheral white blood cells of decay-accelerating factor (CD55) in patients with active ulcerative colitis. (2004) >> Department of Medicine and Medical Science, Okayama University Graduate School of Medicine and Dentistry, Japan. 18Fujita, Teizo, 4Makidono, Chiho, 8Yamamoto, Kazuhide, 13Mizuno, Motowo, 4Hiraoka, Sakiko, 6Nasu, Junichirou, 17Okada, Hiroyuki, 38Shiratori, Yasushi.[Interluekin-1 beta genetic polymorphism influences the impact of cytochrome P 2C19 genotype on the cure rate of H. pylori eradication therapy] (2004) >> Department of Medicine and Medical Science, Okayama University Graduate School of Medicine and Dentistry. 3Take, Susumu, 13Mizuno, Motowo, 3Ishiki, Kuniharu, 17Okada, Hiroyuki, 38Shiratori, Yasushi.Characterization of elongated Helicobacter pylori isolated from a patient with gastric-mucosa-associated lymphoid-tissue lymphoma. (2004) >> Department of Medicine and Medical Science, Okayama University Graduate School of Medicine and Dentistry, 2-5-1, Shikata-cho, Okayama 700-8558, Japan. 3Hayashi, Shunji, 2Fujinami, Yoshihito, 4Takenaka, Ryuta, 13Mizuno, Motowo, 3Toyokawa, Tatsuya, 4Hirai, Yoshikazu, 10Oguma, Keiji, 6Yokota, Kenji, 17Okada, Hiroyuki, 38Shiratori, Yasushi.Pachydermoperiostosis associated with juvenile polyps of the stomach and gastric adenocarcinoma. (2004) >> Department of Medicine and Medical Science, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. 1Kawamoto, Hirofumi, 1Okano, Nobuaki, 13Mizuno, Motowo, 9Okazaki, Hiroaki, 4Hamazaki, Shuji, 1Ikeda, Fusao, 17Okada, Hiroyuki, 38Shiratori, Yasushi.Immune response in Helicobacter pylori-induced low-grade gastric-mucosa-associated lymphoid tissue (MALT) lymphoma. (2004) >> Department of Pathology, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. 1Saitou, Daizou, 13Mizuno, Motowo, 4Hirai, Yoshikazu, 16Yoshino, Tadashi, 10Oguma, Keiji, 6Yokota, Kenji, 1Hayashi, Shyunji, 2Yamasaki, Rie, 17Okada, Hiroyuki, 3Akagi, Tadaatsu.
Science Trivia (2) [Interactive math & science trivia questions]
|
|